European Protein grows in a challenged market

European Protein, a Danish producer of fermented proteins for feed, presents its 2025 annual report with a doubling of EBITDA compared to the previous year.

The progress marks another year of double-digit growth for the family-owned company during a period in which the market for specialised proteins has otherwise been characterised by challenges.

Globally, livestock production is experiencing increasing disease pressure, which is driving demand for solutions that can strengthen animals’ natural resistance and robustness. The trend is evident in Europe, but in Asia and South America, feed producers and livestock producers are also seeking new approaches.

“Disease challenges are growing worldwide, and this creates a real need for solutions that support animal health in a natural way,”

says Jens Legarth, CEO of European Protein and continues:

“Our fermented proteins deliver exactly that—enhanced robustness without compromise. The fact that we can double our EBITDA while the protein industry struggles with profitability shows that tomorrow’s solutions are already in demand today.”

European Protein exits 2025 with an EBITDA of € 1.1 million and a pre-tax profit of € 0.9 million.

Growth continues in 2026

For the group, growth is expected to continue into 2026. The new fermentation facility in Malaysia is expected to be commissioned in the summer of 2026, while the investment in doubling the capacity at the U.S. fermentation plant can now be fully utilised in 2026 – investments that position European Protein and its sister companies to meet rising global demand.